SUBSTITUTED 2,4-DIAMINOQUINAZOLINES AND 2,4-DIAMINO-8-ALKYLPURINES AS ANTAGONISTS OF THE NEUROKININ-2 (NK2) RECEPTOR

被引：8
|
作者：
JACOBS, RT [1 ]
MAUGER, RC [1 ]
ULATOWSKI, TG [1 ]
AHARONY, D [1 ]
BUCKNER, CK [1 ]
机构：
[1] ZENECA PHARMACEUT, DEPT PHARMACOL, WILMINGTON, DE 19850 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1995年 / 5卷 / 23期
关键词：
D O I：
10.1016/0960-894X(95)00502-K
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Modification of the heterocyclic nucleus of a lead pyrrolopyrimidine (1) found to be active as an antagonist at the neurokinin-2 (NK2) receptor is described. Compounds based on the purine nucleus (3) were found to be particularly interesting, and were modified in the C(2), C(4) and C(8) substituents to afford compounds with high potency.
引用
收藏
页码：2879 / 2884
页数：6
相关论文
共 50 条
  • [21] Neurokinin-2 (NK-2) receptor antagonism by tolterodine tartrate
    Meglasson, MD
    Clark, MA
    Wheeler, GJ
    Haber, CL
    JOURNAL OF UROLOGY, 2003, 169 (04): : 41 - 41
  • [22] NK2 ANTAGONISTS AND THE ROLE OF NK2 RECEPTORS
    HAGAN, RM
    BERESFORD, IJM
    ELLIOTT, PJ
    BALL, DI
    SHELDRICK, RLG
    IRELAND, SJ
    PRITCHARD, JM
    MCELROY, AB
    WARD, P
    REGULATORY PEPTIDES, 1992, : S8 - S8
  • [23] 2,4-Diaminoquinazolines as Dual Toll-like Receptor (TLR) 7/8 Modulators for the Treatment of Hepatitis B Virus
    Embrechts, Werner
    Herschke, Florence
    Pauwels, Frederik
    Stoops, Bart
    Last, Stefaan
    Pieters, Serge
    Pande, Vineet
    Pille, Geert
    Amssoms, Katie
    Smyej, Ilham
    Dhuyvetter, Deborah
    Scholliers, Annick
    Mostmans, Wendy
    Van Dijck, Kris
    Van Schoubroeck, Bertrand
    Thone, Tine
    De Pooter, Dorien
    Fanning, Gregory
    Jonckers, Tim H. M.
    Horton, Helen
    Raboisson, Pierre
    McGowan, David
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (14) : 6236 - 6246
  • [24] Synthesis of highly functionalized 2,4-diaminoquinazolines as anticancer and anti-HIV agents
    Yan, Sheng-Jiao
    Zheng, Han
    Huang, Chao
    Yan, Yu-Yun
    Lin, Jun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (15) : 4432 - 4435
  • [25] INHIBITION OF MAMMALIAN DIHYDROFOLATE-REDUCTASE BY SELECTED 2,4-DIAMINOQUINAZOLINES AND RELATED COMPOUNDS
    RICHTER, WE
    MCCORMACK, JJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1974, 17 (09) : 943 - 947
  • [26] Discovery of potent CCR4 antagonists: Synthesis and structure-activity relationship study of 2,4-diaminoquinazolines
    Yokoyama, Kazuhiro
    Ishikawa, Noriko
    Igarashi, Susumu
    Kawano, Noriyuki
    Hattori, Kazuyuki
    Miyazaki, Takahiro
    Ogino, Shin-ichi
    Matsumoto, Yuzo
    Takeuchi, Makoto
    Ohta, Mitsuaki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (14) : 7021 - 7032
  • [27] SR 48968, A NEUROKININ A (NK2) RECEPTOR ANTAGONIST
    EMONDSALT, X
    ADVENIER, C
    LEFUR, G
    BRELIERE, JC
    REGULATORY PEPTIDES, 1992, : S4 - S4
  • [28] Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase
    Khabnadideh, S
    Pez, D
    Musso, A
    Brun, R
    Pérez, LMR
    González-Pacanowska, D
    Gilbert, IH
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (07) : 2637 - 2649
  • [29] A SINGLE MUTATION OF THE NEUROKININ-2 (NK2) RECEPTOR PREVENTS AGONIST-INDUCED DESENSITIZATION - DIVERGENT CONFORMATIONAL REQUIREMENTS FOR NK2 RECEPTOR SIGNALING AND AGONIST-INDUCED DESENSITIZATION IN XENOPUS OOCYTES
    NEMETH, K
    CHOLLET, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) : 27601 - 27605
  • [30] The effects of C5-substituted 2,4-diaminoquinazolines on selected transcript expression in spinal muscular atrophy cells
    Gentillon, Cinsley
    Connell, Andrew J.
    Kirk, Ryan W.
    Butchbach, Matthew E. R.
    PLOS ONE, 2017, 12 (06):
12345